Altimmune (ALT) Goodwill & Intangibles (2010 - 2023)
Altimmune (ALT) reported Goodwill & Intangibles of $12.4 million for Q3 2023, little changed year-over-year from $12.4 million in Q3 2022, and little changed on a QoQ basis from $12.4 million in Q2 2023.
Altimmune (ALT) has 14 years of Goodwill & Intangibles data on file, last reported at $12.4 million in Q3 2023.
- Quarterly Goodwill & Intangibles changed 0.0% year-over-year to $12.4 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $12.4 million (changed 0.0% YoY) and the FY2022 annual result came in at $12.4 million, changed 0.0% from the prior year.
- Goodwill & Intangibles steadied at $12.4 million in Q3 2023 per ALT's latest filing, from $12.4 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $14.5 million in Q4 2019 and bottomed at $12.4 million in Q4 2021.
- The 5-year median for Goodwill & Intangibles is $12.8 million (2020), against an average of $13.1 million.
- The widest annual swing landed in 2019, when Goodwill & Intangibles tumbled 63.8%; it then increased 7.42% in 2021.
- Tracing ALT's Goodwill & Intangibles over 5 years: stood at $14.5 million in 2019, then slipped by 11.26% to $12.8 million in 2020, then retreated by 3.16% to $12.4 million in 2021, then changed by 0.0% to $12.4 million in 2022, then changed by 0.0% to $12.4 million in 2023.
- Per Business Quant, the three latest ALT Goodwill & Intangibles figures stand at $12.4 million (Q3 2023), $12.4 million (Q2 2023), and $12.4 million (Q1 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Altimmune | 379.61 Mn | 379.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 12.42 Mn |
| Jun 30, 2023 | 12.42 Mn |
| Mar 31, 2023 | 12.42 Mn |
| Dec 31, 2022 | 12.42 Mn |
| Sep 30, 2022 | 12.42 Mn |
| Jun 30, 2022 | 12.42 Mn |
| Mar 31, 2022 | 12.42 Mn |
| Dec 31, 2021 | 12.42 Mn |
| Sep 30, 2021 | 12.99 Mn |
| Jun 30, 2021 | 13.73 Mn |
| Mar 31, 2021 | 12.88 Mn |
| Dec 31, 2020 | 12.82 Mn |
| Sep 30, 2020 | 13.55 Mn |
| Jun 30, 2020 | 12.79 Mn |
| Mar 31, 2020 | 12.74 Mn |
| Dec 31, 2019 | 14.45 Mn |
| Sep 30, 2019 | 14.45 Mn |
| Jun 30, 2019 | 14.44 Mn |
| Mar 31, 2019 | 14.43 Mn |
| Dec 31, 2018 | 38.87 Mn |
| Sep 30, 2018 | 38.34 Mn |
| Jun 30, 2018 | 38.87 Mn |
| Mar 31, 2018 | 39.85 Mn |
| Dec 31, 2017 | 38.25 Mn |
| Sep 30, 2017 | 47.92 Mn |
| Jun 30, 2017 | 73.53 Mn |
| Mar 31, 2017 | 2.35 Mn |
| Dec 31, 2016 | 33.24 Mn |
| Sep 30, 2016 | 2.35 Mn |
| Jun 30, 2016 | 2.35 Mn |
| Mar 31, 2016 | 2.35 Mn |
| Dec 31, 2015 | 39.86 Mn |
| Sep 30, 2015 | 2.35 Mn |
| Jun 30, 2015 | 2.35 Mn |
| Mar 31, 2015 | 2.35 Mn |
| Dec 31, 2014 | 2.35 Mn |
| Jun 30, 2014 | 2.35 Mn |
| Mar 31, 2014 | 2.35 Mn |
| Dec 31, 2013 | 2.35 Mn |
| Sep 30, 2013 | 2.35 Mn |
| Jun 30, 2013 | 2.35 Mn |
| Mar 31, 2013 | 2.35 Mn |
| Dec 31, 2012 | 2.35 Mn |
| Sep 30, 2012 | 2.35 Mn |
| Jun 30, 2012 | 2.35 Mn |
| Mar 31, 2012 | 2.35 Mn |
| Dec 31, 2011 | 2.35 Mn |
| Sep 30, 2011 | 2.35 Mn |
| Jun 30, 2011 | 2.35 Mn |
| Dec 31, 2010 | 2.35 Mn |